Univercells launches cell and gene therapy CDMO

The new company will revamp infrastructure to help address a structural lack of capacity and scarcity of bioprocessing expertise

picture of

Breaking News

Ritedose selects ChargePoint Technology’s transfer solution for biomanufacturing project

The AseptiSafe Bio Transfer Valve uses an enhanced decontamination step to provide a validated 6-log reduction in ...

FDA approves Xellia US facility for CMO injectables

The increased capacity will be used to grow and scale Xellia’s own pipeline as well as widening its offering of CMO ...

High-throughput technologies: a paradigm shift in biopharmaceutical development

The growing demand for innovative biopharmaceutical products is putting pressure on the pharmaceutical biotechnology ...

Zenith on the buzzwords for pharma 2020

Joe Haugh, Zenith Technologies CEO, describes 2019 as a real watershed year, with topics such as Industry 4.0, ...

Catalent partners with Biohaven on fast-dissolve migraine treatment

The FDA has approved Biohaven Pharmaceutical Holding Company's NURTEC ODT (rimegepant) for the acute treatment of ...

Dipharma expands CDMO offering with new QC lab in the US

New lab has enabled Italy-based Dipharma to now offer full services from discovery to marketed drugs

Delivering certainty in uncertain times

Contract manufacturing organisations (CMOs) in the pharmaceutical sector operate at the sharp end of an industry in ...

Catalent support of Blueprint Medicines results in FDA approval

Blueprint Medicines’ Precision Therapy AYVAKIT has been approved by the FDA

Facility visit: Lonza

The Swiss CDMO has opened its manufacturing base in Visp, letting Manufacturing Chemist tour the site and find out what ...

Integrated solutions offer fast-track development for biopharmaceuticals

At the heart of any successful medicine launch is a robust manufacturing process that will reliably make the product in ...

John Baker: life sciences need to address the reproducibility crisis

The head of product innovation at Abcam says it is crucial that the whole industry finds ways to de-risk the route to ...

Lonza reveals process development roadmap for cell and gene therapies

Behnam Baghbaderani of Lonza Pharma & Biotech examines four manufacturing challenges inherent to the production of ...

Catalent client gets FDA approval for generic bronchodilator

Approval has marked the first generic metered-dose inhaler to be approved by the FDA in over twenty years and will now ...

Alcami acquires TriPharm Services

US-based Alcami has acquired a new sterile fill-finish company near the Research Triangle Park in North Carolina